HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Renal dysfunction and increased risk of cardiotoxicity with trastuzumab therapy: a new challenge in cardio-oncology.

AuthorsAdriana Albini, Francesco Donatelli, Chiara Focaccetti, Mario Milco D'Elios, Douglas M Noonan
JournalInternal and emergency medicine (Intern Emerg Med) Vol. 7 Issue 5 Pg. 399-401 (Oct 2012) ISSN: 1970-9366 [Electronic] Italy
PMID22941411 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Comment)
Chemical References
  • Antibodies, Monoclonal, Humanized
  • Trastuzumab
Topics
  • Antibodies, Monoclonal, Humanized (adverse effects)
  • Antineoplastic Combined Chemotherapy Protocols (adverse effects)
  • Breast Neoplasms (drug therapy)
  • Female
  • Heart Diseases (chemically induced)
  • Humans
  • Renal Insufficiency (complications)
  • Trastuzumab

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: